If there’s one thing we all agree upon when it comes to cancer, it’s that nobody wants to deal with it. While the world has made tremendous medical progress in recent years, and cancer isn’t a synonym for a death sentence anymore, it’s great to see that scientists never stop looking for ways to treat it.
SciTechDaily.com writes about a new study that brings great news for those people over the age of 70 years old: combining three simple treatments could reduce the risk of developing invasive cancer for these folks by 61%.
Vitamin D, omega-3 fatty acids, and working out could make the cancer risk go down by 61%
After Dr. Heike Bischoff-Ferrari of the University Hospital, Zurich, and her colleagues conducted the ‘DO-HEALTH’ three-year trial upon more than 2,000 individuals from five European countries, it was found that if people aged 70+ rely on high-dose vitamin D, omega-3 fatty acids, as well as a SHEP (simple home strength exercise program), the risk of developing invasive cancer goes down by 61%.
But how can such a formula be so beneficial? Well, vitamin D hampers the development of cancer cells, and omega-3 could slow down the transformation of normal cells into cancer cells. As for physical exercise, which has proven to be hugely beneficial for human health overall so many times, it can improve immune function and also decrease inflammation in this case.
Bischoff-Ferrari explained as SciTechDaily.com quotes:
In DO-HEALTH, our aim was to test promising combined interventions for cancer prevention taking advantage of potentially small additive benefits from several public health strategies,
In fact, novel cancer treatments aim to block multiple pathways for cancer development by combining several agents. We translated this concept into cancer prevention.
However, clinical studies are still needed to say for sure if the three treatments can be used against the development of cancer. Here’s another important statement made by Bischoff-Ferrari, as quoted by the same source:
Future studies should verify the benefit of combined treatments in the prevention of cancer, also extending to longer follow-ups beyond the three-year duration assessed in this trial.
The new findings were published in the journal Frontiers in Aging.